Flosulide

This classification denotes a cyclooxygenase inhibitor with the molecular formula C16H13F2NO4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GVR41S4ZHJ, chemically known as n-(6-(2,4-difluorophenoxy)-1-oxo-5-indanyl)methanesulfonamide but generally known as flosulide, which bears US NIH Compound Identifier 71246. European Medicines Agency schedules Flosulide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07655MIG. The term FLOSULIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). FLOSULIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule flosulide under HS 29350090 and SITC 51580. As of Q4 2014, FLOSULIDE remains the US FDA Preferred Term for this commodity. Flosulide bears US NLM identifiers UMLS ID C0117885 and NCI Concept Code C65698. SMILES: S(=O)(=O)(NC1CC2CCC(=O)C2CC1OC1C(F)CC(F)CC1)C.